CHGA and neuroendocrine carcinoma: The diagnosis of NEC depends on histopathological recognition and reactivity to neuroendocrine markers such as synaptophysin, cytokeratin, and chromogranin A. The WHO classified tumor activity based on mitotic count and Ki‐67 proliferation index into NET G1, NET G2, NET G3, and NEC.